Radioactive iodine therapy; effect on functioning metastases of adenocarcinoma of the thyroid - PubMed
- ️Tue Jan 01 1946
Radioactive iodine therapy; effect on functioning metastases of adenocarcinoma of the thyroid
S M SEIDLIN et al. J Am Med Assoc. 1946.
No abstract available
Similar articles
-
[Radioactive tracing of metastases of thyroid cancer].
LAMARQUE P, THIBAUD E, PAGES A, GARY-BOBO J. LAMARQUE P, et al. J Radiol Electrol Arch Electr Medicale. 1954;35(3-4):274-5. J Radiol Electrol Arch Electr Medicale. 1954. PMID: 13202097 French. No abstract available.
-
Value of radioactive iodine I 131 in the diagnosis and treatment of thyroid cancer.
LEENHARDT P, POURQUIER H. LEENHARDT P, et al. Montp Med. 1956 Jul-Aug;50(1):68-76. Montp Med. 1956. PMID: 13378396 English, French. No abstract available.
-
Radioactive iodine therapy: effect on functioning metastases of adenocarcinoma of the thyroid.
Seidlin SM, Marinelli LD, Oshry E. Seidlin SM, et al. CA Cancer J Clin. 1990 Sep-Oct;40(5):299-317. doi: 10.3322/canjclin.40.5.299. CA Cancer J Clin. 1990. PMID: 2118414
-
[On the treatment of thyroid cancer and its metastases with radioiodine 131].
CLOSUIT M, LAPP R, LERCH P. CLOSUIT M, et al. Helv Med Acta. 1951 Oct;18(4-5):469-74. Helv Med Acta. 1951. PMID: 14873181 Undetermined Language. No abstract available.
-
[CME: Radioactive iodine therapy in thyroid cancer].
Steinert HC, Aberle S. Steinert HC, et al. Praxis (Bern 1994). 2015 Nov 11;104(23):1235-43; quiz 1244-5. doi: 10.1024/1661-8157/a002189. Praxis (Bern 1994). 2015. PMID: 26558927 Review. German.
Cited by
-
Verburg FA, Luster M, Giovanella L. Verburg FA, et al. Eur J Nucl Med Mol Imaging. 2017 Feb;44(2):183-184. doi: 10.1007/s00259-016-3526-y. Eur J Nucl Med Mol Imaging. 2017. PMID: 27726016 No abstract available.
-
Radio-Iodide Treatment: From Molecular Aspects to the Clinical View.
De la Vieja A, Riesco-Eizaguirre G. De la Vieja A, et al. Cancers (Basel). 2021 Feb 27;13(5):995. doi: 10.3390/cancers13050995. Cancers (Basel). 2021. PMID: 33673669 Free PMC article. Review.
-
Schwengber WK, Mota LM, Nava CF, Rodrigues JAP, Zanella AB, De Souza Kuchenbecker R, Scheffel RS, Maia AL, Dora JM. Schwengber WK, et al. Arch Endocrinol Metab. 2021 Nov 1;64(6):824-832. doi: 10.20945/2359-3997000000302. Epub 2020 Oct 21. Arch Endocrinol Metab. 2021. PMID: 33085995 Free PMC article.
-
RET kinase inhibitors for RET-altered thyroid cancers.
Vodopivec DM, Hu MI. Vodopivec DM, et al. Ther Adv Med Oncol. 2022 Jun 21;14:17588359221101691. doi: 10.1177/17588359221101691. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 35756966 Free PMC article. Review.